PT2078038E - Agentes tensioativos reconstituídos apresentando propriedades melhoradas - Google Patents

Agentes tensioativos reconstituídos apresentando propriedades melhoradas

Info

Publication number
PT2078038E
PT2078038E PT78252129T PT07825212T PT2078038E PT 2078038 E PT2078038 E PT 2078038E PT 78252129 T PT78252129 T PT 78252129T PT 07825212 T PT07825212 T PT 07825212T PT 2078038 E PT2078038 E PT 2078038E
Authority
PT
Portugal
Prior art keywords
improved properties
reconstituted surfactants
reconstituted
surfactants
surfactant protein
Prior art date
Application number
PT78252129T
Other languages
English (en)
Inventor
Tore Curstedt
Jan Johansson
Bengt Robertson
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39079026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2078038(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of PT2078038E publication Critical patent/PT2078038E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395Alveolar surfactant peptides; Pulmonary surfactant peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785Alveolar surfactant peptides; Pulmonary surfactant peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
PT78252129T 2006-10-13 2007-09-28 Agentes tensioativos reconstituídos apresentando propriedades melhoradas PT2078038E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06021521 2006-10-13

Publications (1)

Publication Number Publication Date
PT2078038E true PT2078038E (pt) 2013-12-12

Family

ID=39079026

Family Applications (1)

Application Number Title Priority Date Filing Date
PT78252129T PT2078038E (pt) 2006-10-13 2007-09-28 Agentes tensioativos reconstituídos apresentando propriedades melhoradas

Country Status (36)

Country Link
US (2) US8183210B2 (pt)
EP (1) EP2078038B1 (pt)
JP (2) JP5405307B2 (pt)
KR (1) KR101328851B1 (pt)
CN (2) CN101522711B (pt)
AR (2) AR063263A1 (pt)
AU (1) AU2007306075B2 (pt)
BR (1) BRPI0715317B1 (pt)
CA (1) CA2666344C (pt)
CL (1) CL2007002931A1 (pt)
CO (1) CO6400235A2 (pt)
CY (1) CY1114716T1 (pt)
DK (1) DK2078038T3 (pt)
EA (1) EA015802B1 (pt)
ES (1) ES2438727T3 (pt)
GE (1) GEP20125531B (pt)
HK (2) HK1134497A1 (pt)
HR (1) HRP20140052T1 (pt)
IL (1) IL198075A (pt)
JO (1) JO2963B1 (pt)
MA (1) MA31062B1 (pt)
ME (2) MEP12109A (pt)
MX (1) MX343064B (pt)
MY (1) MY148127A (pt)
NO (1) NO342038B1 (pt)
NZ (1) NZ576189A (pt)
PE (1) PE20081184A1 (pt)
PL (1) PL2078038T3 (pt)
PT (1) PT2078038E (pt)
RS (1) RS53172B (pt)
SI (1) SI2078038T1 (pt)
TN (1) TN2009000099A1 (pt)
TW (1) TWI388333B (pt)
UA (1) UA94477C2 (pt)
WO (1) WO2008044109A1 (pt)
ZA (1) ZA200902481B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2049554A4 (en) 2006-07-20 2011-06-29 Univ Rochester Medical Ct SYNTHETIC PULMONARY SURFACTANT AND USE THEREOF
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8399406B2 (en) * 2009-06-05 2013-03-19 Chiesi Farmaceutici S.P.A. Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
CN101948526B (zh) * 2010-09-02 2012-12-05 华东理工大学 一种肺泡表面活性蛋白质(sp-b和sp-c)的分离纯化方法
WO2013120058A2 (en) * 2012-02-09 2013-08-15 University Of Rochester Novel sp-b & sp-c peptides, synthetic lung surfactants, and use thereof
US20130303726A1 (en) * 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
WO2014079898A1 (en) 2012-11-21 2014-05-30 Chiesi Farmaceutici S.P.A. Reconstituted pulmonary surfactants
US10717777B2 (en) 2015-12-17 2020-07-21 The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Synthetic lung surfactant with enhanced stability and effectiveness
US11179446B2 (en) 2016-03-07 2021-11-23 Lundquist Institute For Biomedical Innovation At Harbor—Ucla Medical Center Compositions and method for administering PPARgamma agonists, surfactant peptides and phosopholipids
MA46034A (fr) * 2016-08-24 2021-04-28 Chiesi Farm Spa Formulation pharmaceutique stable comprenant une composition de surfactant pulmonaire reconstitué
EP4097128A1 (en) 2020-01-28 2022-12-07 Chiesi Farmaceutici S.p.A. Polypeptides having improved properties

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2163860A1 (en) * 1993-06-30 1995-01-12 Chung C. Hsu Method for preparing liposomes
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
US7065342B1 (en) * 1999-11-23 2006-06-20 Gofigure, L.L.C. System and mobile cellular telephone device for playing recorded music
ITMI20021058A1 (it) 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
EP2049554A4 (en) * 2006-07-20 2011-06-29 Univ Rochester Medical Ct SYNTHETIC PULMONARY SURFACTANT AND USE THEREOF
EP1997502A1 (en) 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
EP2022798A1 (en) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides

Also Published As

Publication number Publication date
CY1114716T1 (el) 2016-10-05
BRPI0715317B1 (pt) 2021-10-05
KR20090083892A (ko) 2009-08-04
US20100004173A1 (en) 2010-01-07
NO20091441L (no) 2009-06-23
US20130079275A1 (en) 2013-03-28
TN2009000099A1 (en) 2010-08-19
AR113422A2 (es) 2020-04-29
TWI388333B (zh) 2013-03-11
CN103169947A (zh) 2013-06-26
AR063263A1 (es) 2009-01-14
JP5405307B2 (ja) 2014-02-05
CN101522711B (zh) 2013-11-13
NZ576189A (en) 2011-09-30
EP2078038B1 (en) 2013-11-20
CN101522711A (zh) 2009-09-02
JP2010505937A (ja) 2010-02-25
NO342038B1 (no) 2018-03-19
US8183210B2 (en) 2012-05-22
PL2078038T3 (pl) 2014-05-30
IL198075A (en) 2016-04-21
HRP20140052T1 (hr) 2014-02-28
EA200900373A1 (ru) 2009-10-30
JO2963B1 (en) 2016-03-15
JP2013241449A (ja) 2013-12-05
AU2007306075A1 (en) 2008-04-17
EP2078038A1 (en) 2009-07-15
CA2666344A1 (en) 2008-04-17
MEP12109A (en) 2011-12-20
GEP20125531B (en) 2012-05-25
BRPI0715317A2 (pt) 2013-07-09
UA94477C2 (ru) 2011-05-10
ZA200902481B (en) 2010-07-28
PE20081184A1 (es) 2008-09-26
ME02326B (me) 2016-06-20
MX343064B (es) 2016-10-24
CN103169947B (zh) 2014-10-29
CO6400235A2 (es) 2012-03-15
HK1134497A1 (en) 2010-04-30
SI2078038T1 (sl) 2014-02-28
MX2009003638A (es) 2009-04-22
CA2666344C (en) 2017-04-18
WO2008044109A1 (en) 2008-04-17
TW200824705A (en) 2008-06-16
EA015802B1 (ru) 2011-12-30
MA31062B1 (fr) 2010-01-04
ES2438727T3 (es) 2014-01-20
AU2007306075B2 (en) 2012-08-09
RS53172B (en) 2014-06-30
HK1185274A1 (en) 2014-02-14
KR101328851B1 (ko) 2013-11-14
DK2078038T3 (da) 2013-12-02
IL198075A0 (en) 2011-08-01
CL2007002931A1 (es) 2008-03-24
MY148127A (en) 2013-02-28
US9238058B2 (en) 2016-01-19

Similar Documents

Publication Publication Date Title
PT2078038E (pt) Agentes tensioativos reconstituídos apresentando propriedades melhoradas
MY159464A (en) Reconstituted surfactant composition containing analogs of surfactant protein b (sp-b) and surfactant protein c (sp-c)
MX2009012675A (es) Tensioactivos reconstituidos que tienen propiedades mejoradas.
UA95235C2 (en) Glucagon-like-peptide-2 (glp-2) analogues
MX2019011592A (es) Peptidos y analogos de peptidos protectores de los tejidos para evitar y tratar padecimientos y desordenes asociados con daño de los tejidos.
TW200745334A (en) Compositions and methods for producing a composition
MX2010002716A (es) Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago.
ZA201001054B (en) Peptide with reduced dimer formation
SG10201803541TA (en) Biologically active c-terminal arginine-containing peptides
MX2010001543A (es) Peptidos de surfactante pulmonar sintetico.
TW200740456A (en) GLP-1 pharmaceutical compositions
GB0616061D0 (en) Peptides and uses thereof
GB0520872D0 (en) Onion flavour compounds and use
TW200517125A (en) Pharmaceutical composition for treatment of solid cancers
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof
AU2346301A (en) Use of parvoviruses for improving the general condition of tumour patients or patients having chronic or consumptive diseases
UA96003C2 (en) PHARMACEUTICAL COMPOSITION [Aib8,35]hGLP-1(7-36)NH2
DE602007009797D1 (de) Antitumorheilmittel, Medikament, Zusammensetzung und Verwendung davon
WO2007070907A3 (en) Therapeutic compositions